Clorox Company, led by their new
CFO Luc Bellet, is on a firm footing despite remarks by Jim Cramer on the company's weak earnings. The company exceeded expectations in Q2 of the fiscal year 2025, with a notably
24% EPS beat. On top of that, Clorox raised its guidance after its quarterly sales topped estimates, prompting a higher rating from Jefferies. Their strategic moves and commitment are reflected in the raising of the
regular quarterly dividend to $1.22 per share. Clorox boosted its FY25 outlook, following the sale of its Better Health VMS Business. Despite the recent stock fall after Q2 earnings,
Clorox's share performance over the last three years shows 7.4% CAGR for shareholders. The company's impressive Q2 results included a
revenue of $1.69 billion and an EPS surge to $1.54. Clorox also disclosed their
partnership with M2030 to advance supply chain climate action, indicating their commitment to sustainability. However, there are still challenges ahead, with market share gains providing both opportunities and vulnerabilities.
Clorox Company CLX News Analytics from Thu, 21 Mar 2024 07:00:00 GMT to Thu, 20 Feb 2025 09:03:12 GMT -
Rating 5
- Innovation 2
- Information 7
- Rumor -2
